Phase 2 STARLIGHT study participants, particularly those with the macular phenotype, experienced meaningful gains in visual acuity at 48 weeks.
Kenneth C. Fan, MD, MBA
Advertisement
Kenneth C. Fan, MD, MBA, is in practice with Retina Consultants of Texas in Bellaire, TX.
Articles by Kenneth C. Fan, MD, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Glaukos receives FDA approval for Epioxa topical therapy for keratoconus
2
News from Orlando: AAO 2025 highlights research across all areas of eyecare
3
AAO 2025: Philip J. Ferrone, MD, highlights safety and efficacy findings of gildeuretinol in Stargardt disease
4
AAO 2025: Glaucoma laser surgery with Joel S. Schuman, MD, FACS
5
.png "Optometry Times"){kind=logo}
